CD8A and B-cell chronic lymphocytic leukemia: Indeed, previous published work found a normal cytokine response in CMV-specific CD8+ T cells in patients with CLL, when CMV peptide was presented via lymphoblastoid cell lines or healthy donor B cells and in a controlled B: T cell ratio.